Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis.
Qianquan Ma,Qianquan Ma,Changsheng Xing,Wenyong Long,Helen Yicheng Wang,Qing Liu,Rongfu Wang,Rongfu Wang,Rongfu Wang +8 more
TLDR
The biological interplay between gut-brain axis is discussed, and how this communication may be dysregulated in neurological diseases is explored, and new insights in modification of gut microbiota composition are highlighted.Abstract:
Development of central nervous system (CNS) is regulated by both intrinsic and peripheral signals. Previous studies have suggested that environmental factors affect neurological activities under both physiological and pathological conditions. Although there is anatomical separation, emerging evidence has indicated the existence of bidirectional interaction between gut microbiota, i.e., (diverse microorganisms colonizing human intestine), and brain. The cross-talk between gut microbiota and brain may have crucial impact during basic neurogenerative processes, in neurodegenerative disorders and tumors of CNS. In this review, we discuss the biological interplay between gut-brain axis, and further explore how this communication may be dysregulated in neurological diseases. Further, we highlight new insights in modification of gut microbiota composition, which may emerge as a promising therapeutic approach to treat CNS disorders.read more
Citations
More filters
Journal ArticleDOI
Toxicity of Microplastics and Nanoplastics in Mammalian Systems
TL;DR: The prevailing data suggest that micro- and nanoplastic accumulation in mammalian and human tissues would likely have negative, yet unclear long-term consequences, and there is a need for cellular and systemic toxicity due to micro-and nanoplastics to be better illuminated, and the underlying mechanisms defined by further work.
Journal ArticleDOI
The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology.
TL;DR: The status of the knowledge and the open questions in the field focusing on the function of intestinal microbial metabolites or products on CNS cells during healthy and inflammatory conditions, such as multiple sclerosis, Alzheimer's and Parkinson’s diseases, and also neuropsychiatric disorders are discussed.
Journal ArticleDOI
Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease.
TL;DR: As aging together with poor diet and gut-derived inflammatory response due to dysbiosis contributes to the pathogenesis of AD, modification of gut microbial composition by uptake of probiotic-rich food can act as a preventive/therapeutic option for AD.
Journal ArticleDOI
Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics.
Artemiy S. Silantyev,Luca Falzone,Massimo Libra,Olga I. Gurina,Karina Sh Kardashova,Taxiarchis Konstantinos Nikolouzakis,Alexander E. Nosyrev,Chris W. Sutton,Panayiotis D. Mitsias,Aristides M. Tsatsakis +9 more
TL;DR: Both benefits and pitfalls of molecular biology and proteomics analyses are discussed, including the different mass spectrometry-based analytical techniques, highlighting how these investigation strategies are powerful tools to study the biology of glioblastoma, as well as to develop advanced methods for the management of this pathology.
Journal ArticleDOI
Gut microbial molecules in behavioural and neurodegenerative conditions.
TL;DR: Bacterial metabolites with known or suspected neuromodulatory activity are described, mechanisms of signalling pathways from the gut microbiota to the brain are defined and direct effects that gut bacterial molecules are likely exerting on specific brain cells are discussed.
References
More filters
Journal ArticleDOI
NLRP3 inflammasome-driven pathways in depression: Clinical and preclinical findings.
Fernanda Neutzling Kaufmann,Ana Paula Costa,Gabriele Ghisleni,Alexandre Paim Diaz,Ana Lúcia S. Rodrigues,Hugo Peluffo,Manuella P. Kaster +6 more
TL;DR: This review discusses both preclinical and clinical evidence that links the assembly of the NLRP3 complex and the subsequent proteolysis and release of the pro-inflammatory cytokines interleukin-1β (IL-1 β) and interleokin-18 ( IL-18) in chronic stress models and patients with MDD and focuses on the therapeutic potential of targeting theNLRP3 inflammasome complex to improve stress resilience and depressive symptoms.
Journal ArticleDOI
Accumulation of α-synuclein in the bowel of patients in the pre-clinical phase of Parkinson’s disease
David A Hilton,Madeleine Stephens,Leanne Kirk,Philip Edwards,Ross Potter,John Zajicek,Ellie Broughton,Hannah Hagan,Camille Carroll +8 more
TL;DR: It is shown that α-synuclein accumulation occurs prior to the onset of motor symptoms in the upper, as well as the lower gastrointestinal tract, remains present in serial biopsies until the onsetof motor symptoms and is predominantly composed of phosphorylated α- synuclein.
Journal ArticleDOI
Gut microbiota in early pediatric multiple sclerosis: a case-control study.
Helen Tremlett,Douglas Fadrosh,Ali A. Faruqi,Feng Zhu,Janace Hart,Shelly Roalstad,Jennifer Graves,Susan V. Lynch,Emmanuelle Waubant +8 more
TL;DR: Microbial community profiles were compared between early onset pediatric multiple sclerosis (MS) and control children similar for age and sex.
Journal ArticleDOI
Diffusion of Macromolecules in the Brain: Implications for Drug Delivery
Daniel J. Wolak,Robert G. Thorne +1 more
TL;DR: How quantitative diffusion measurements can be used to better understand and potentially improve upon CNS drug delivery by modeling delivery within and across species, screening drugs and drug conjugates, evaluating methods for altering drug distribution, and appreciating important changes in drug distribution that may occur with CNS disease or injury are discussed.
Journal ArticleDOI
The gut microbiota-derived metabolite trimethylamine N -oxide is elevated in Alzheimer’s disease
Nicholas M. Vogt,Kymberleigh A. Romano,Kymberleigh A. Romano,Burcu F. Darst,Corinne D. Engelman,Sterling C. Johnson,Cynthia M. Carlsson,Sanjay Asthana,Kaj Blennow,Kaj Blennow,Henrik Zetterberg,Barbara B. Bendlin,Federico E. Rey +12 more
TL;DR: CSF TMAO is higher in individuals with MCI and AD dementia compared to cognitively-unimpaired individuals, and elevated CSF T MAO is associated with biomarkers of AD pathology (phosphorylated tau and phosphorylation tau/Aβ42) and neuronal degeneration (total t Tau and neurofilament light chain protein).
Related Papers (5)
Host microbiota constantly control maturation and function of microglia in the CNS
Daniel Erny,Anna Lena Hrabě de Angelis,Diego Jaitin,Peter Wieghofer,Ori Staszewski,Eyal David,Hadas Keren-Shaul,Tanel Mahlakõiv,Kristin Jakobshagen,Thorsten Buch,Vera Schwierzeck,Olaf Utermöhlen,Eunyoung Chun,Wendy S. Garrett,Kathy D. McCoy,Andreas Diefenbach,Peter Staeheli,Bärbel Stecher,Ido Amit,Marco Prinz +19 more
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
Timothy R. Sampson,Justine W. Debelius,Taren Thron,Stefan Janssen,Gauri G. Shastri,Zehra Esra Ilhan,Collin Challis,Catherine E. Schretter,Sandra Rocha,Viviana Gradinaru,Marie-Françoise Chesselet,Ali Keshavarzian,Kathleen M. Shannon,Rosa Krajmalnik-Brown,Pernilla Wittung-Stafshede,Rob Knight,Sarkis K. Mazmanian +16 more
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
John F. Cryan,Timothy G. Dinan +1 more